RvD1, RvD2, and RvE1 exerted their effects through mTOR and MAP/ERK signaling in models of depression, while RvD1, RvD2, and MaR1 through the NF-κB pathway in models of neurodegeneration and neurological disorders. The gene discussed is MTOR; the disease is depressive symptom measurement.